Borviz 3.5 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Borviz 3.5 mg Injection

Borviz 3.5 mg Injection

Borviz 3.5 mg Injection contains bortezomib 3.5 mg and is a proteasome inhibitor used in cancer treatment. It is mainly used for multiple myeloma and mantle cell lymphoma. The medicine is administered by a healthcare professional according to the prescribed treatment schedule.

BUY NOW

Category

Bortezomib works by inhibiting proteasomes, which disrupts the normal breakdown of proteins inside cancer cells and can lead to their death. It may be used alone or in combination with other medicines depending on the specific cancer and treatment protocol. Blood counts, liver function, kidney function, and other clinical parameters may require regular monitoring during therapy. The dose and administration schedule are individualized by the treating oncologist according to the patient’s condition and treatment response.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 3.5 mg
Dosage Form Injection
Pack Size 1 Vial
Route of Administration Intravenous or Subcutaneous
Manufacturer Intas Pharmaceuticals Ltd

Product Also Known As

Borviz 3.5mg Injection, Borviz 3.5 mg Injection, Bortezomib 3.5mg Injection, Bortezomib 3.5 mg Injection, Bortezomib 3.5mg Vial, Bortezomib Oncology Injection